In this episode of Dr. Lawyer Breakdown, Dr. Joseph Ramos and host Bradford Keaty examine kratom, a botanical substance that has become increasingly visible in Colorado and across the country. Dr. Ramos explains how kratom affects the central nervous system, including its interaction with mu receptors associated with opioid medications. At lower doses, it can have stimulant effects, while higher doses can cause sedation and potentially dangerous respiratory effects. The conversation also explores how kratom is metabolized in the body, how concentrated products containing 7-hydroxymitragynine can increase potency and why interactions with common medications such as Benadryl, certain antidepressants and benzodiazepines can create serious risks. Dr. Ramos emphasizes that kratom is more than an ordinary herbal tea or supplement and discusses its potential for addiction.
The episode then examines the legal response to kratom, including Colorado’s Daniel Bregman Act, which introduced restrictions involving labeling, dosage, concentration and age requirements. Dr. Ramos explains how the death of Daniel Bregman helped bring attention to the need for consumer protections and why product liability claims involving kratom can be particularly complicated. From questionable product purity and concentrated ingredients to manufacturers, distributors and retailers pointing fingers at one another, identifying responsibility can require extensive investigation. The conversation highlights the role of product liability litigation in encouraging safer products and greater accountability, while emphasizing the importance of quality, accurate labeling and consumer awareness.
Watch the full video
Things to Know About Kratom: 6 Key Takeaways
- Kratom Is More Than an Herbal Supplement: Although kratom comes from a naturally occurring plant, Dr. Ramos explains that it interacts with receptors in the body associated with opioid medications and can have significant effects on the central nervous system.
- Concentrated Products Can Increase the Danger: The active compound mitragynine is metabolized into 7-hydroxymitragynine. Dr. Ramos warns that manufacturers can concentrate this component into small bottles, tablets or capsules, creating products that are much more potent than traditional kratom tea.
- Drug Interactions Can Have Serious Consequences: Kratom is metabolized through the liver’s cytochrome P450 enzyme system, which also processes many common medications. Combining substances such as kratom and Benadryl can interfere with how the body clears them, potentially allowing dangerous levels to build up.
- Kratom Can Be Addictive and Affect Breathing: Because kratom interacts with receptors associated with opioids, Dr. Ramos explains that it can have addictive properties. At higher doses, its sedative effects can also cause respiratory depression and potentially life-threatening complications.
- Colorado’s Daniel Bregman Act Introduced Important Consumer Protections: The legislation established requirements involving product labeling, dosage, concentration and age restrictions. Dr. Ramos discusses how these measures help consumers better understand what they are purchasing and reduce the risks associated with highly concentrated products.
- Product Liability Cases Can Help Make Industries Safer: When a kratom product is improperly labeled, manufactured, distributed or contaminated, there may be grounds for a legal claim. However, identifying the responsible parties can be difficult when manufacturers, suppliers and retailers point to one another, making thorough investigation essential.
